148 related articles for article (PubMed ID: 37916832)
21. Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study.
Yang X; Eriksson M; Czene K; Lee A; Leslie G; Lush M; Wang J; Dennis J; Dorling L; Carvalho S; Mavaddat N; Simard J; Schmidt MK; Easton DF; Hall P; Antoniou AC
J Med Genet; 2022 Dec; 59(12):1196-1205. PubMed ID: 36162852
[TBL] [Abstract][Full Text] [Related]
22. Risk prediction for breast Cancer in Han Chinese women based on a cause-specific Hazard model.
Wang L; Liu L; Lou Z; Ding L; Guan H; Wang F; Yu L; Xiang Y; Zhou F; Xue F; Yu Z
BMC Cancer; 2019 Feb; 19(1):128. PubMed ID: 30732565
[TBL] [Abstract][Full Text] [Related]
23. A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study.
Kong J; Zheng J; Cai J; Wu S; Diao X; Xie W; Chen X; Liao C; Yu H; Fan X; Huang C; Liu Z; Chen W; Lv Q; Qin H; Huang J; Lin T
Cancer Commun (Lond); 2019 Nov; 39(1):80. PubMed ID: 31775884
[TBL] [Abstract][Full Text] [Related]
24. Comparing the prediction of prostate biopsy outcome using the Chinese Prostate Cancer Consortium (CPCC) Risk Calculator and the Asian adapted Rotterdam European Randomized Study of Screening for Prostate Cancer (ERSPC) Risk Calculator in Chinese and European men.
Chen R; Verbeek JFM; Yang Y; Song Z; Sun Y; Roobol MJ
World J Urol; 2021 Jan; 39(1):73-80. PubMed ID: 32279141
[TBL] [Abstract][Full Text] [Related]
25. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
Olsen M; Fischer K; Bossuyt PM; Goetghebeur E
BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164
[TBL] [Abstract][Full Text] [Related]
26. Development and external validation of a prediction model for brain metastases in patients with metastatic breast cancer.
Wu Q; Sun MS; Liu YH; Ye JM; Xu L
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12333-12353. PubMed ID: 37432458
[TBL] [Abstract][Full Text] [Related]
27. Lung Cancer Risk Prediction Nomogram in Nonsmoking Chinese Women: Retrospective Cross-sectional Cohort Study.
Guo L; Meng Q; Zheng L; Chen Q; Liu Y; Xu H; Kang R; Zhang L; Liu S; Sun X; Zhang S
JMIR Public Health Surveill; 2023 Jan; 9():e41640. PubMed ID: 36607729
[TBL] [Abstract][Full Text] [Related]
28. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
29. OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations.
Pan Z; Zhang R; Shen S; Lin Y; Zhang L; Wang X; Ye Q; Wang X; Chen J; Zhao Y; Christiani DC; Li Y; Chen F; Wei Y
EBioMedicine; 2023 Feb; 88():104443. PubMed ID: 36701900
[TBL] [Abstract][Full Text] [Related]
30. A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study.
Zhang H; Xie P; Li Z; Huang R; Feng W; Kong Y; Xu F; Zhao L; Song Q; Li J; Zhang B; Fan J; Qiao Y; Xie X; Zheng S; He J; Wang K
Diagn Pathol; 2019 May; 14(1):35. PubMed ID: 31054583
[TBL] [Abstract][Full Text] [Related]
31. Development and external multicenter validation of Chinese Prostate Cancer Consortium prostate cancer risk calculator for initial prostate biopsy.
Chen R; Xie L; Xue W; Ye Z; Ma L; Gao X; Ren S; Wang F; Zhao L; Xu C; Sun Y;
Urol Oncol; 2016 Sep; 34(9):416.e1-7. PubMed ID: 27185342
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a lifestyle-based model for colorectal cancer risk prediction: the LiFeCRC score.
Aleksandrova K; Reichmann R; Kaaks R; Jenab M; Bueno-de-Mesquita HB; Dahm CC; Eriksen AK; Tjønneland A; Artaud F; Boutron-Ruault MC; Severi G; Hüsing A; Trichopoulou A; Karakatsani A; Peppa E; Panico S; Masala G; Grioni S; Sacerdote C; Tumino R; Elias SG; May AM; Borch KB; Sandanger TM; Skeie G; Sánchez MJ; Huerta JM; Sala N; Gurrea AB; Quirós JR; Amiano P; Berntsson J; Drake I; van Guelpen B; Harlid S; Key T; Weiderpass E; Aglago EK; Cross AJ; Tsilidis KK; Riboli E; Gunter MJ
BMC Med; 2021 Jan; 19(1):1. PubMed ID: 33390155
[TBL] [Abstract][Full Text] [Related]
33. Nomogram model and risk score to predict 5-year risk of progression from prediabetes to diabetes in Chinese adults: Development and validation of a novel model.
Han Y; Hu H; Liu Y; Wang Z; Liu D
Diabetes Obes Metab; 2023 Mar; 25(3):675-687. PubMed ID: 36321466
[TBL] [Abstract][Full Text] [Related]
34. How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?
Bongers MER; Karhade AV; Setola E; Gambarotti M; Groot OQ; Erdoğan KE; Picci P; Donati DM; Schwab JH; Palmerini E
Clin Orthop Relat Res; 2020 Oct; 478(10):2300-2308. PubMed ID: 32433107
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of a novel nomogram for predicting the occurrence of myopia in schoolchildren: A prospective cohort study.
Guo C; Ye Y; Yuan Y; Wong YL; Li X; Huang Y; Bao J; Mao G; Chen H
Am J Ophthalmol; 2022 Oct; 242():96-106. PubMed ID: 35750213
[TBL] [Abstract][Full Text] [Related]
36. Development and Validation of a Scoring System for Hemorrhage Risk in Brain Arteriovenous Malformations.
Chen Y; Han H; Meng X; Jin H; Gao D; Ma L; Li R; Li Z; Yan D; Zhang H; Yuan K; Wang K; Zhang Y; Zhao Y; Jin W; Li R; Lin F; Chao X; Lin Z; Hao Q; Wang H; Ye X; Kang S; Li Y; Sun S; Liu A; Wang S; Zhao Y; Chen X
JAMA Netw Open; 2023 Mar; 6(3):e231070. PubMed ID: 36857052
[TBL] [Abstract][Full Text] [Related]
37. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
Elife; 2023 Mar; 12():. PubMed ID: 36971353
[TBL] [Abstract][Full Text] [Related]
38. Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
Brentnall AR; Cuzick J; Buist DSM; Bowles EJA
JAMA Oncol; 2018 Sep; 4(9):e180174. PubMed ID: 29621362
[TBL] [Abstract][Full Text] [Related]
39. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
